shortagewatch

Home / Cardiovascular system / Atorvastatin and Amlodipine

ATC C10BX03 · Lipid Modifying Agents in Combination with Other Drugs

Atorvastatin and Amlodipine shortage

As of 2 Nov 2026, Atorvastatin and Amlodipine has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 17 products from 5 companies.

Countries2/15
Products17packs or presentations
Companies53 listed
Short since11 Dec 202511 months ago
Earliest return8 Dec 2026company estimate
Main reasonIncreased demand

Timeline

CanadaJapan
20262027MYLAN-AMLODIPINE/ATORVASTATIN (1x90BTL)MYLAN-AMLODIPINE/ATORVASTATIN (1x90BTL)MYLAN-AMLODIPINE/ATORVASTATIN (90BT)MYLAN-AMLODIPINE/ATORVASTATIN (90BT)アマルエット配合錠1番「サワイ」アマルエット配合錠1番「サワイ」アマルエット配合錠2番「サワイ」アマルエット配合錠2番「サワイ」アマルエット配合錠3番「サワイ」アマルエット配合錠3番「サワイ」アマルエット配合錠4番「サワイ」アマルエット配合錠4番「サワイ」アマルエット配合錠4番「日医工」アマルエット配合錠4番「日医工」アマルエット配合錠3番「日医工」アマルエット配合錠3番「日医工」アマルエット配合錠1番「トーワ」アマルエット配合錠1番「トーワ」アマルエット配合錠2番「日医工」アマルエット配合錠2番「日医工」アマルエット配合錠2番「トーワ」アマルエット配合錠2番「トーワ」アマルエット配合錠1番「日医工」アマルエット配合錠1番「日医工」アマルエット配合錠3番「トーワ」アマルエット配合錠3番「トーワ」アマルエット配合錠4番「トーワ」アマルエット配合錠4番「トーワ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Sawai4 4887Nichi-Iko4Towa (Pensa)4 4553Viatris3 VTRSBgp2

Listed: Viatris VTRS · Nasdaq, Sawai 4887 · Tokyo, Towa (Pensa) 4553 · Tokyo

Compared with similar medicines

ATC group C10BX · Lipid Modifying Agents in Combination with Other Drugs
Atorvastatin and Amlodipine2/15Rosuvastatin and Acetylsalicylic Acid1/15Rosuvastatin and Amlodipine1/15

Affected products

CountryProductCompanySinceExpected backReason
CAMYLAN-AMLODIPINE/ATORVASTATIN (1x90BTL)MYLAN PHARMACEUTICALS ULC1 Aug 20268 Dec 2026Increased demand
Demand increase for the drug
CAMYLAN-AMLODIPINE/ATORVASTATIN (90BT)MYLAN PHARMACEUTICALS ULC5 Aug 20268 Dec 2026Increased demand
Demand increase for the drug
CACADUET (1x90 BTL CA) anticipatedBGP PHARMA ULC8 Nov 20268 Dec 2026Manufacturing problem
Disruption of the manufacture of the drug
CAMYLAN-AMLODIPINE/ATORVASTATIN (1x90 BTL CA) anticipatedMYLAN PHARMACEUTICALS ULC17 Nov 20268 Dec 2026Increased demand
Demand increase for the drug
CACADUET (1 x 90BTL) anticipatedBGP PHARMA ULC15 Dec 202612 Jan 2027Manufacturing problem
Disruption of the manufacture of the drug
アマルエット配合錠1番「サワイ」 limited沢井製薬11 Dec 2025not givenIncreased demand
アマルエット配合錠2番「サワイ」 limited沢井製薬11 Dec 2025not givenIncreased demand
アマルエット配合錠3番「サワイ」 limited沢井製薬11 Dec 2025not givenIncreased demand
アマルエット配合錠4番「サワイ」 limited沢井製薬11 Dec 2025not givenIncreased demand
アマルエット配合錠4番「日医工」 limited日医工15 Dec 2025not givenIncreased demand
アマルエット配合錠3番「日医工」 limited日医工13 Feb 2026not givenIncreased demand
アマルエット配合錠1番「トーワ」東和薬品18 Jun 2026not givenManufacturing problem
アマルエット配合錠2番「日医工」 limited日医工25 Jun 2026not givenIncreased demand
アマルエット配合錠2番「トーワ」東和薬品9 Jul 2026not givenManufacturing problem
アマルエット配合錠1番「日医工」日医工9 Oct 2026not givenQuality problem or recall
Quality problem
アマルエット配合錠3番「トーワ」 limited東和薬品22 Oct 2026not givenManufacturing problem
アマルエット配合錠4番「トーワ」 limited東和薬品22 Oct 2026not givenManufacturing problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.